Jazz Pharmaceuticals logo

Jazz Pharmaceuticals

North America, California, United States, Palo Alto

Description

Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments.

Investor Profile

Jazz Pharmaceuticals has made 3 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Series A (67%)
  • Series B (33%)

Country Focus

  • The Netherlands (67%)
  • United States (33%)

Industry Focus

  • Health Care
  • Medical Device
  • Health Diagnostics
  • Medical
  • Nanotechnology
  • Wearables
  • Biopharma
  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jazz Pharmaceuticals frequently co-invest with?

Solas BioVentures
North America, Tennessee, United States, Chattanooga
Co-Investments: 1
imec.xpand
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
Invest-NL
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
BOM
Europe, Noord-Brabant, The Netherlands, Tilburg
Co-Investments: 2
imec
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Innovation Industries
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Rex Health Ventures
North America, North Carolina, United States, Raleigh
Co-Investments: 1
15th Rock
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1

What are some of recent deals done by Jazz Pharmaceuticals?

Onera Health

Eindhoven, Noord-Brabant, The Netherlands

Onera Health is a global leader in sleep diagnostics and monitoring.

Health CareHealth DiagnosticsMedicalMedical DeviceNanotechnologyWearables
Series BJul 29, 2021
Amount Raised: $12,486,072
Onera Health

Eindhoven, Noord-Brabant, The Netherlands

Onera Health is a global leader in sleep diagnostics and monitoring.

Health CareHealth DiagnosticsMedicalMedical DeviceNanotechnologyWearables
Series AApr 24, 2019
Amount Raised: $9,101,251
Arrivo BioVentures LLC

Morrisville, North Carolina, United States

Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.

BiopharmaBiotechnologyHealth CareMedical Device
Series AMay 25, 2016
Amount Raised: $49,000,000